Q2FY23 Financial Summary and Strategic Highlights slide image

Q2FY23 Financial Summary and Strategic Highlights

Significant changes to accelerate growth and improve competitiveness Leveraging enterprise synergies with tech development centers and strategic customer relationships 8 Tech development centers Strategic customer relationships Adding new centralized technology centers to existing battery and microelectronics centers to leverage across multiple operating units: • Cardiac implantables Becoming a true partner to our customers and driving strong strategic relationships ✓ Single point of contact for large customers such as governments, large healthcare systems, and GPOs to buy across the Medtronic portfolio • Enabling technologies Neuromodulation implantables . Surgical technologies ✓ Example: CRM team helped accelerate trajectory of Neuromod development Investor Meetings | November 2022 Medtronic
View entire presentation